Adamas Pharmaceuticals (United States)

Adamas Pharmaceuticals is a specialty pharmaceutical company focused on developing treatments for chronic neurological diseases. Based in Emeryville, California, Adamas created Gocovri (amantadine extended-release), the first and only FDA-approved treatment for dyskinesia in Parkinson’s disease patients taking levodopa. The company’s expertise includes CNS drug development, movement disorders, and neurodegenerative disease therapies.